Sep 2026· International Journal of Oncology· Vol 69· 0 citations· 158 references
Medicine
TL;DR
The present review synthesizes recent discoveries to explore the relationship between macrophage polarization and lung cancer, with a specific focus on miRNA-mediated regulatory mechanisms in lung cancer therapy and a reference point to inform future prevention and treatment strategies for lung cancer.
Abstract
Lung cancer is among the most prevalent and fatal cancers worldwide, with its progression heavily shaped by the tumor microenvironment (TME). As key immune cell populations within the TME of lung cancer, macrophages are involved in the entire process of tumor initiation and development. Macrophage polarization serves as a critical link between inflammation and tumorigenesis and is broadly divided into classically activated M1 and alternatively activated M2 phenotypes. These phenotypes exert tumor-suppressive and tumor-promoting effects, respectively, by secreting distinct cytokine profiles. MicroRNAs (miRNAs/miRs) are a class of endogenous small non-coding RNAs that play broad roles in the malignant progression of lung cancer by regulating various cellular processes, including proliferation, resistance to apoptosis, and metabolic reprogramming. Emerging evidence suggests that miRNAs such as miR-335-5p, miR-106a-5p and miR-99b regulate M1/M2 macrophage polarization by targeting key pathways in lung cancer. Through these regulatory events, miRNAs exert synergistic effects on multiple tumor hallmarks, including proliferation, invasion, migration, apoptosis, angiogenesis, cell cycle progression, stemness maintenance, and epithelial-mesenchymal transition. Collectively, these events drive lung cancer progression and influence therapeutic efficacy. The present review synthesizes recent discoveries to explore the relationship between macrophage polarization and lung cancer, with a specific focus on miRNA-mediated regulatory mechanisms in lung cancer therapy. Ultimately, the present review aimed to provide new insight and a reference point to inform future prevention and treatment strategies for lung cancer.
Current insights into exosome-driven macrophage polarization in HCC are summarized, providing a potential immunotherapeutic strategy for restoring antitumor immunity and improving HCC patient prognosis.
An-Nie L. Chen, Minmin Zhu· Frontiers in Immunology· 0 citations
This minireview summarizes recent insights into the HuD-lncRNA axis and epigenetic regulation of miR-204, evaluates their clinical implications, and discusses emerging multimodal approaches that target the miR-204 network for more effective precision therapy in lung cancer.
Xin-Ling Zhang, Jia-Yi Zhu, Jian-Lan Yang et al.· World Journal of Clinical On...· 0 citations
Investigation of whether miR-155-5p and miR-3535 represent regulators capable of driving coordinated functional reprogramming of both, tumor cells and macrophages found they modulate tumor-intrinsic immune checkpoint expression and functional macrophage polarization in a coordinated way.
Key lncRNAs involved in TAM polarization in PDAC are summarized, highlighting their roles in inducing the M2 phenotype and promoting PDAC progression through epigenetic modifications, ceRNA networks, and signal transduction pathways.
Hong-Shi Sun, Jia Wang, Zhong-Bo Xie et al.· Journal of physiology and bi...· 0 citations
This data demonstrates that this dual-targeting strategy strongly induced potent reprogramming of M2-polarized macrophages, establishing it as a superior immunotherapeutic framework.
Sezen Gul, J. Vergnaud, Qing-Lin Wang et al.· Molecular Pharmaceutics· 0 citations
Clinical translation remains limited by dependence on retrospective transcriptomic datasets, insufficient mechanistic validation, lack of standardized assays, and scarce prospective clinical evidence, but pyroptosis-associated lncRNAs represent a promising link between tumor progression and immune regulation, with cons...
Chou-Yi Hsu, Bilal Abdulmajeed Mukhlif, O. Nematov et al.· Cell Cycle· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.